qPCR Assay Market Report

qPCR Assay Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR976

Increasing intervention of the government with regards to funding for research and development activities coupled with rising R&D activities in proteomics and genomics and advancement in technology is expected to drive the qPCR assay market during the forecast period. Growing approaches for new diagnostic tools and techniques, evaluation of benefits to patient outcome and developing genome profiling techniques are the drivers expected to fuel the qPCR assay market in the recent years. qPCR allows quantification and amplification of a real time targeted DNA molecule. It requires small sample and provides with higher sensitivity, efficiency and accuracy than the conventional PCR. 

On the basis of product, the market is segmented into qPCR consumables, qPCR instruments and qPCR services. On the basis of application the qPCR assay market is classified into drug discovery, drug development, diagnosis, research and others. qPCR technology is majorly used in various diagnostic and research applications such as quantification of nucleic acid standards, rare allele detection, viral load quantification,  separation and enrichment of mixtures, low-fold copy number discrimination and  NGS libraries quantification. 

Geographically, cosmetic implant market is studied with respect to four regions as North America, Europe, RoW and Asia Pacific. The increasing requirement of personalized healthcare genetic testing in various disease areas such as cancer and diabetes is expected to fuel the qPCR assay market. The U.S. coding guidelines has assigned codes to reimbursement policies and healthcare services. Increasing prevalence of cardiovascular disorders and genetic disorders coupled with the rising investments in proteomics and genomics is expected to drive the qPCR assay market in the North American region during the forecast period. Asia Pacific market is projected to grow rapidly due to the development of various new technologies by the research institutes of emerging economies such as India, Japan and China.

Some key players in this market are Affymetrix Inc., Cepheid, Qiagen, Abbott Laboratories, Agilent Technologies, Bio-Rad, Beckman Coulter Inc., Becton, Dickinson and Co., Sigma-Aldrich Corp, GE Healthcare, Life Technologies and Roche. Two most commonly used methods for labeling and detecting PCR products are TaqMan Assay or fluorogenic 5’ nuclease chemistry and SYBR Chemistry Green dye chemistry by LifeTechnologies.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA